A detailed history of Wellington Management Group LLP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 122,334 shares of MIRM stock, worth $5.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
122,334
Previous 75,416 62.21%
Holding current value
$5.47 Million
Previous $2.58 Million 85.07%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$33.68 - $44.74 $1.58 Million - $2.1 Million
46,918 Added 62.21%
122,334 $4.77 Million
Q2 2024

Aug 13, 2024

BUY
$23.57 - $34.85 $117,237 - $173,343
4,974 Added 7.06%
75,416 $2.58 Million
Q1 2024

May 15, 2024

BUY
$24.92 - $30.02 $1.76 Million - $2.11 Million
70,442 New
70,442 $1.77 Million
Q1 2023

May 12, 2023

BUY
$19.19 - $24.1 $1,880 - $2,361
98 Added 0.06%
154,750 $3.72 Million
Q4 2022

Feb 13, 2023

SELL
$17.59 - $23.83 $189,022 - $256,077
-10,746 Reduced 6.5%
154,652 $3.02 Million
Q3 2022

Nov 14, 2022

SELL
$19.98 - $29.44 $241,718 - $356,165
-12,098 Reduced 6.82%
165,398 $3.48 Million
Q1 2022

May 16, 2022

SELL
$15.5 - $23.93 $11,082 - $17,109
-715 Reduced 0.4%
177,496 $3.91 Million
Q4 2021

Feb 11, 2022

SELL
$13.05 - $19.35 $2.43 Million - $3.61 Million
-186,489 Reduced 51.13%
178,211 $2.84 Million
Q3 2021

Nov 15, 2021

BUY
$13.95 - $20.18 $260,865 - $377,366
18,700 Added 5.4%
364,700 $7.27 Million
Q2 2021

Aug 16, 2021

BUY
$15.84 - $20.6 $3.77 Million - $4.91 Million
238,300 Added 221.26%
346,000 $5.98 Million
Q1 2021

May 17, 2021

BUY
$16.29 - $21.92 $363,267 - $488,816
22,300 Added 26.11%
107,700 $2.14 Million
Q4 2020

Feb 12, 2021

BUY
$15.75 - $25.45 $1.35 Million - $2.17 Million
85,400 New
85,400 $1.49 Million

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.64B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.